GSK poaches Merck KGaA exec to replace departing U.S. pharma president Bailey

GlaxoSmithKline has seen plenty of changes across its executive ranks over the last couple of years as CEO Emma Walmsley took the helm, but they’re still coming. Monday, the company said Jack Bailey, its U.S. pharma president, would step down.